Evidence map›Paper›PMID 36798764›Full record

ArticleHeliyon2023

APPRAISE-RS: Automated, updated, participatory, and personalized treatment recommender systems based on GRADE methodology.

Beatriz López, Oscar Raya, Evgenia Baykova, Marc Saez, David Rigau, Ruth Cunill, Sacramento Mayoral, Carme Carrion, Domènec Serrano, Xavier Castells

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Beatriz LópezControl Engineering and Intelligent Systems (eXiT), University of Girona, Spain.
Oscar RayaControl Engineering and Intelligent Systems (eXiT), University of Girona, Spain.
Evgenia BaykovaInstitute of Health Care (ICS-IAS), Girona, Spain.
Marc SaezResearch Group on Statistics, Econometrics and Health, University of Girona, Spain.
David RigauCochrane Iberoamerica, Barcelona, Spain.
Ruth CunillSant Joan de Deu-Numancia Health Park, Barcelona, Spain.
Sacramento MayoralInstitute of Health Care (ICS-IAS), Girona, Spain.
Carme CarrionHealth Lab Research Group, Universitat Oberta de Catalunya, Spain.
Domènec SerranoInstitute of Health Care (ICS-IAS), Girona, Spain.
Xavier CastellsTransLab Research Group, Dept. of Medical Sciences, University of Girona, Spain.
Universitat de Girona · ESInstitut d'Assistència Sanitària · ESIberoamerican Cochrane Centre · ESUniversitat Oberta de Catalunya · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Clinical practice guidelines (CPGs) have become fundamental tools for evidence-based medicine (EBM). However, CPG suffer from several limitations, including obsolescence, lack of applicability to many patients, and limited patient participation. This paper presents APPRAISE-RS, which is a methodology that we developed to overcome these limitations by automating, extending, and iterating the methodology that is most commonly used for building CPGs: the GRADE methodology. Method: APPRAISE-RS relies on updated information from clinical studies and adapts and automates the GRADE methodology to generate treatment recommendations. APPRAISE-RS provides personalized recommendations because they are based on the patient's individual characteristics. Moreover, both patients and clinicians express their personal preferences for treatment outcomes which are considered when making the recommendation (participatory). Rule-based system approaches are used to manage heuristic knowledge. Results: APPRAISE-RS has been implemented for attention deficit hyperactivity disorder (ADHD) and tested experimentally on 28 simulated patients. The resulting recommender system (APPRAISE-RS/TDApp) shows a higher degree of treatment personalization and patient participation than CPGs, while recommending the most frequent interventions in the largest body of evidence in the literature (EBM). Moreover, a comparison of the results with four blinded psychiatrist prescriptions supports the validation of the proposal. Conclusions: APPRAISE-RS is a valid methodology to build recommender systems that manage updated, personalized and participatory recommendations, which, in the case of ADHD includes at least one intervention that is identical or very similar to other drugs prescribed by psychiatrists.

Indexed as

Attention deficit hyperactivity disorderEvidence-based medicineMeta-analysisTreatment recommender systems

Identifiers

PMID36798764
PMCPMC9925880
OpenAlexW4317936926

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.